Latest News & Updates
Breaking News
31 minutes ago
Simantini Singh Deo
Other trending news you may like to read
NeuroSigma Launches Second-Generation Monarch eTNS System For Children With ADHD In The U.S.
NeuroSigma launches second-generation Monarch eTNS System for children with ADHD in the U.S.
Simantini Singh Deo
Revagenix Promotes Peter Smith To Chief Scientific Officer To Lead Next Phase Of Growth
Revagenix promotes Peter Smith to Chief Scientific Officer to lead its next phase of growth.
Simantini Singh Deo
IMUNON Reports Positive Phase 2 Results For IMNN-001 In Advanced Ovarian Cancer Study
IMUNON reports positive Phase 2 results for IMNN-001 in advanced ovarian cancer study.
Simantini Singh Deo
Akari Therapeutics And Whitehawk Therapeutics Partner To Advance Next-Generation ADC Cancer Treatments
Akari Therapeutics partners with Whitehawk Therapeutics to advance next-generation ADC cancer treatments.
Simantini Singh Deo
